newsfilter
← Latest News
GlobeNewswire·

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (NASDAQ:PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the